Kinnari Patel
Presidente presso ROCKET PHARMACEUTICALS, INC.
Patrimonio netto: 11 M $ in data 31/05/2024
Profilo
Kinnari Patel's career history includes current and former positions as well as education.
Currently, Dr. Patel is the President, Chief Operating Officer, and Head of R&D at Rocket Pharmaceuticals, Inc. Prior to this, Dr. Patel held the position of Chief Operating Officer & Head of Development at Rocket Pharmaceuticals Ltd.
from 2016 to 2021.
From 2010 to 2014, Dr. Patel worked at Bristol Myers Squibb Co. as the Head of US Risk Management.
In terms of education, Dr. Patel obtained an undergraduate and doctorate degree from the University of the Sciences in Philadelphia.
Additionally, Dr. Patel holds an MBA from The Leonard N Stern School of Business.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 16/05/2024 | 511 574 ( 0.56% ) | 11 M $ | 31/05/2024 |
Posizioni attive di Kinnari Patel
| Società | Posizione | Inizio |
|---|---|---|
| ROCKET PHARMACEUTICALS, INC. | Presidente | - |
Precedenti posizioni note di Kinnari Patel
| Società | Posizione | Fine |
|---|---|---|
Rocket Pharmaceuticals Ltd.
 Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rocket Pharmaceuticals Ltd. operates as a biotechnology company which focuses on developing gene therapy treatment for undertreated diseases. The firm’s pipeline includes Fanconi Anemia, Pyruvate Kinase Deficiency, Leukocyte Adhesion Deficiency-1 and Infantile Malignant Osteopetrosis. It also develops an AAV-based therapy program for an undisclosed rare pediatric disease. The company is headquartered in New York, NY. | Direttore operativo | 01/02/2021 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 01/04/2014 |
Formazione di Kinnari Patel
| University of the Sciences in Philadelphia | Doctorate Degree |
| The Leonard N Stern School of Business | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| ROCKET PHARMACEUTICALS, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Rocket Pharmaceuticals Ltd.
Rocket Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Rocket Pharmaceuticals Ltd. operates as a biotechnology company which focuses on developing gene therapy treatment for undertreated diseases. The firm’s pipeline includes Fanconi Anemia, Pyruvate Kinase Deficiency, Leukocyte Adhesion Deficiency-1 and Infantile Malignant Osteopetrosis. It also develops an AAV-based therapy program for an undisclosed rare pediatric disease. The company is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Kinnari Patel
